CanSino Biologics Inc
SSE:688185

Watchlist Manager
CanSino Biologics Inc Logo
CanSino Biologics Inc
SSE:688185
Watchlist
Price: 61.23 CNY -0.21% Market Closed
Market Cap: 7B CNY
Have any thoughts about
CanSino Biologics Inc?
Write Note

Wall Street
Price Targets

Price Targets Summary
CanSino Biologics Inc

Wall Street analysts forecast CanSino Biologics Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CanSino Biologics Inc is 67.67 CNY with a low forecast of 54.54 CNY and a high forecast of 82.61 CNY.

Lowest
Price Target
54.54 CNY
11% Downside
Average
Price Target
67.67 CNY
11% Upside
Highest
Price Target
82.61 CNY
35% Upside
CanSino Biologics Inc Competitors:
Price Targets
ARVN
Arvinas Inc
238% Upside
4547
Kissei Pharmaceutical Co Ltd
9% Upside
SBBC
Simply Better Brands Corp
75% Upside
MARKSANS
Marksans Pharma Ltd
7% Upside
000999
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
21% Upside
ORCHPHARMA
Orchid Pharma Ltd
9% Downside
039200
Oscotec Inc
74% Upside
300723
Yipinhong Pharmaceutical Co Ltd
43% Upside

Revenue
Forecast

Revenue Estimate
CanSino Biologics Inc

The compound annual growth rate of CanSino Biologics Inc's revenue for the next 4 years is 64%.

N/A
Past Growth
64%
Estimated Growth
Estimates Accuracy
-31%
Average Miss

Operating Income
Forecast

Operating Income Estimate
CanSino Biologics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
CanSino Biologics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CanSino Biologics Inc's stock price target?
Price Target
67.67 CNY

According to Wall Street analysts, the average 1-year price target for CanSino Biologics Inc is 67.67 CNY with a low forecast of 54.54 CNY and a high forecast of 82.61 CNY.

What is CanSino Biologics Inc's Revenue forecast?
Projected CAGR
64%

The compound annual growth rate of CanSino Biologics Inc's revenue for the next 4 years is 64%.

Back to Top